Literature DB >> 28246232

Response to "Association between statin use and ischemic stroke or major hemorrhage in patients taking dabigatran for atrial fibrillation".

Tony Antoniou1, Muhammad Mamdani2, David Juurlink3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28246232      PMCID: PMC5325740          DOI: 10.1503/cmaj.732638

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  5 in total

1.  A comparison of the bioavailability of digoxin in capsule, tablet, and solution taken orally with intravenous digoxin.

Authors:  P F Binnion
Journal:  J Clin Pharmacol       Date:  1976-10       Impact factor: 3.126

2.  Association between statin use and ischemic stroke or major hemorrhage in patients taking dabigatran for atrial fibrillation.

Authors:  Sebastian Haertter; Fenglei Huang; Lionel Riou Franca
Journal:  CMAJ       Date:  2017-02-27       Impact factor: 8.262

3.  Antiretroviral Boosting Agent Cobicistat Increases the Pharmacokinetic Exposure and Anticoagulant Effect of Dabigatran in HIV-Negative Healthy Volunteers.

Authors:  Lori A Gordon; Parag Kumar; Kristina M Brooks; Anela Kellogg; Maryellen McManus; Raul M Alfaro; Khanh Nghiem; Jomy M George; Jay Lozier; Scott R Penzak; Colleen Hadigan
Journal:  Circulation       Date:  2016-12-06       Impact factor: 29.690

4.  Association between statin use and ischemic stroke or major hemorrhage in patients taking dabigatran for atrial fibrillation.

Authors:  Tony Antoniou; Erin M Macdonald; Zhan Yao; Simon Hollands; Tara Gomes; Mina Tadrous; Muhammad M Mamdani; David N Juurlink
Journal:  CMAJ       Date:  2016-11-21       Impact factor: 8.262

5.  Oral bioavailability of dabigatran etexilate (Pradaxa(®) ) after co-medication with verapamil in healthy subjects.

Authors:  Sebastian Härtter; Regina Sennewald; Gerhard Nehmiz; Paul Reilly
Journal:  Br J Clin Pharmacol       Date:  2013-04       Impact factor: 4.335

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.